Kenneth T. Mills
2018
In 2018, Kenneth T. Mills earned a total compensation of $4.9M as President and CEO at Regenxbio, a 93% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $480,800 |
|---|---|
| Option Awards | $3,895,222 |
| Salary | $546,364 |
| Other | $15,813 |
| Total | $4,938,199 |
Mills received $3.9M in option awards, accounting for 79% of the total pay in 2018.
Mills also received $480.8K in non-equity incentive plan, $546.4K in salary and $15.8K in other compensation.
Rankings
In 2018, Kenneth T. Mills' compensation ranked 2,050th out of 14,244 executives tracked by ExecPay. In other words, Mills earned more than 85.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,050 out of 14,244 | 86th |
Division Manufacturing | 737 out of 5,759 | 87th |
Major group Chemicals And Allied Products | 246 out of 2,122 | 88th |
Industry group Drugs | 196 out of 1,811 | 89th |
Industry Biological Products, Except Diagnostic Substances | 41 out of 339 | 88th |
Source: SEC filing on April 11, 2019.
Mills' colleagues
We found four more compensation records of executives who worked with Kenneth T. Mills at Regenxbio in 2018.